Cargando…

WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis

BACKGROUND: WNT16 is critical for bone homeostasis, but the effect of WNT16 in ankylosing spondylitis (AS) is still unknown. Here, we investigated whether WNT16 influences bone formation and pathophysiological changes of AS in an in vitro model. METHODS: The bone tissue from the facet joints was obt...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Sungsin, Weon, Subin, Nam, Bora, Jang, Mi-Ae, Kang, Hyundeok, Kim, Tae-Jong, Park, Ye-Soo, Kim, Tae-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653593/
https://www.ncbi.nlm.nih.gov/pubmed/34879876
http://dx.doi.org/10.1186/s13075-021-02670-0
_version_ 1784611696401186816
author Jo, Sungsin
Weon, Subin
Nam, Bora
Jang, Mi-Ae
Kang, Hyundeok
Kim, Tae-Jong
Park, Ye-Soo
Kim, Tae-Hwan
author_facet Jo, Sungsin
Weon, Subin
Nam, Bora
Jang, Mi-Ae
Kang, Hyundeok
Kim, Tae-Jong
Park, Ye-Soo
Kim, Tae-Hwan
author_sort Jo, Sungsin
collection PubMed
description BACKGROUND: WNT16 is critical for bone homeostasis, but the effect of WNT16 in ankylosing spondylitis (AS) is still unknown. Here, we investigated whether WNT16 influences bone formation and pathophysiological changes of AS in an in vitro model. METHODS: The bone tissue from the facet joints was obtained from seven disease control and seven AS patients. Primary osteoprogenitor cells of the facet joints were isolated using an outgrowth method. Isolated osteoprogenitor cells from both control and AS tissues were analyzed by microarray, RT-qPCR, immunoblotting, and immunohistochemistry. The bone-forming activity of osteoprogenitor cells was assessed by various in vitro assays. β-galactosidase staining and senescence-associated secretory phenotype (SASP) using RT-qPCR were used to assess cell senescence. RESULTS: In microarray analysis, WNT16 expression was significantly elevated in AS osteoprogenitor cells compared to the control. We also validated that WNT16 expression was elevated in AS-osteoprogenitor cells and human AS-bone tissues. WNT16 treatment inhibited bone formation in AS-osteoprogenitor cells but not in the control. Intriguingly, AS-osteoprogenitor cells were stained markedly with β-galactosidase for cell senescence in WNT16 treatment. Furthermore, in an H(2)O(2) stress-induced premature senescence condition, WNT16 treatment increased cell senescence in AS-osteoprogenitor cells and WNT16 treatment under the H(2)O(2) stress condition showed an increase in p21 protein and SASP mRNA expression. The WNT16-induced SASP expression in AS-osteoprogenitor cells was reduced in WNT16 knockdown cultures. CONCLUSION: WNT16 is highly expressed in AS and WNT16 treatment facilitated cell senescence in AS-osteoprogenitor cells during osteoblast differentiation accompanied by suppression of bone formation. The identified role of WNT16 in AS could influence bone loss in AS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02670-0.
format Online
Article
Text
id pubmed-8653593
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86535932021-12-08 WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis Jo, Sungsin Weon, Subin Nam, Bora Jang, Mi-Ae Kang, Hyundeok Kim, Tae-Jong Park, Ye-Soo Kim, Tae-Hwan Arthritis Res Ther Research Article BACKGROUND: WNT16 is critical for bone homeostasis, but the effect of WNT16 in ankylosing spondylitis (AS) is still unknown. Here, we investigated whether WNT16 influences bone formation and pathophysiological changes of AS in an in vitro model. METHODS: The bone tissue from the facet joints was obtained from seven disease control and seven AS patients. Primary osteoprogenitor cells of the facet joints were isolated using an outgrowth method. Isolated osteoprogenitor cells from both control and AS tissues were analyzed by microarray, RT-qPCR, immunoblotting, and immunohistochemistry. The bone-forming activity of osteoprogenitor cells was assessed by various in vitro assays. β-galactosidase staining and senescence-associated secretory phenotype (SASP) using RT-qPCR were used to assess cell senescence. RESULTS: In microarray analysis, WNT16 expression was significantly elevated in AS osteoprogenitor cells compared to the control. We also validated that WNT16 expression was elevated in AS-osteoprogenitor cells and human AS-bone tissues. WNT16 treatment inhibited bone formation in AS-osteoprogenitor cells but not in the control. Intriguingly, AS-osteoprogenitor cells were stained markedly with β-galactosidase for cell senescence in WNT16 treatment. Furthermore, in an H(2)O(2) stress-induced premature senescence condition, WNT16 treatment increased cell senescence in AS-osteoprogenitor cells and WNT16 treatment under the H(2)O(2) stress condition showed an increase in p21 protein and SASP mRNA expression. The WNT16-induced SASP expression in AS-osteoprogenitor cells was reduced in WNT16 knockdown cultures. CONCLUSION: WNT16 is highly expressed in AS and WNT16 treatment facilitated cell senescence in AS-osteoprogenitor cells during osteoblast differentiation accompanied by suppression of bone formation. The identified role of WNT16 in AS could influence bone loss in AS patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02670-0. BioMed Central 2021-12-08 2021 /pmc/articles/PMC8653593/ /pubmed/34879876 http://dx.doi.org/10.1186/s13075-021-02670-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Jo, Sungsin
Weon, Subin
Nam, Bora
Jang, Mi-Ae
Kang, Hyundeok
Kim, Tae-Jong
Park, Ye-Soo
Kim, Tae-Hwan
WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis
title WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis
title_full WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis
title_fullStr WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis
title_full_unstemmed WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis
title_short WNT16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis
title_sort wnt16 elevation induced cell senescence of osteoblasts in ankylosing spondylitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653593/
https://www.ncbi.nlm.nih.gov/pubmed/34879876
http://dx.doi.org/10.1186/s13075-021-02670-0
work_keys_str_mv AT josungsin wnt16elevationinducedcellsenescenceofosteoblastsinankylosingspondylitis
AT weonsubin wnt16elevationinducedcellsenescenceofosteoblastsinankylosingspondylitis
AT nambora wnt16elevationinducedcellsenescenceofosteoblastsinankylosingspondylitis
AT jangmiae wnt16elevationinducedcellsenescenceofosteoblastsinankylosingspondylitis
AT kanghyundeok wnt16elevationinducedcellsenescenceofosteoblastsinankylosingspondylitis
AT kimtaejong wnt16elevationinducedcellsenescenceofosteoblastsinankylosingspondylitis
AT parkyesoo wnt16elevationinducedcellsenescenceofosteoblastsinankylosingspondylitis
AT kimtaehwan wnt16elevationinducedcellsenescenceofosteoblastsinankylosingspondylitis